- Service Name
NeoGenomics Laboratories
- Industry
Healthcare, Diagnostics, Oncology, Cancer Testing
- Main Value Proposition
NeoGenomics delivers precise and actionable insights through advanced oncology diagnostics, enabling personalized patient care.
- Description
NeoGenomics is a leading cancer reference laboratory specializing in precision oncology testing. The company empowers healthcare professionals with advanced diagnostic solutions to optimize patient care and treatment outcomes.
- Key Features
Extensive range of over 500 tests covering major testing modalities; Access to a broad data set with over 2 million patient profiles; Partnership programs for biopharma companies to accelerate drug development; Comprehensive support for patients navigating testing and billing complexities
- Use Cases
Primary scenarios where NeoGenomics is valuable include oncologists seeking personalized treatment options, biopharma companies needing reliable data for drug development, and patients requiring support in understanding their cancer diagnostics.
- Competitive advantages
Leader in precision oncology with a comprehensive test menu; Strong partnerships with biopharma companies for drug development; Robust client support and patient resources to navigate cancer care
- Strengths
NeoGenomics' strengths include its extensive testing capabilities, a large and diverse patient data set, and a commitment to advancing cancer diagnostics through research and innovation.
- Positioning
NeoGenomics positions itself as a leader in precision oncology testing, focusing on delivering innovative solutions that enhance patient care and support healthcare professionals.
- Audience
The target users include oncologists, pathologists, biopharma companies, and cancer patients who benefit from precision testing and support services.
- CTA
Learn more about us
- Tags
Precision Oncology
Cancer Diagnostics
Patient Support
Biopharma Partnerships
- Tagline
When it matters, it matters who you ask.
- Tone of Voice
Professional, supportive, informative
- Differentiation
NeoGenomics stands out in the market by offering a vast array of tests and a unique data set that reflects the diversity of the US population, enhancing the precision of oncology diagnostics.
- Brand Positioning
The brand identity of NeoGenomics is centered around trust, innovation, and a commitment to improving cancer care through advanced diagnostics and partnerships.
- Founded
1998-10-29